Nivolumab in HIV-related non-small-cell lung cancer

被引：25
|
作者：
Hentrich, M. [1 ]
Schipek-Voigt, K. [2 ]
Jager, H. [3 ]
Schulz, S. [1 ]
Schmid, P. [1 ]
Stotzer, O. [2 ]
Bojko, P. [1 ]
机构：
[1] Red Cross Hosp, Dept Hematol & Oncol, Munich, Germany
[2] MVZ Hematol & Oncol, Dept Hematol & Oncol, Munich, Germany
[3] MUC Res, Ctr Infect Dis, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷 / 11期
关键词：
D O I：
10.1093/annonc/mdx321
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2890 / 2890
页数：1
相关论文
共 50 条
  • [1] Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer
    Hasegawa, Takahiro
    Uno, Hajime
    Wei, Lee-Jen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (05): : 492 - 492
  • [2] Effect and biomarker of Nivolumab for non-small-cell lung cancer
    Wang, Li
    Zhao, Deze
    Qin, Kang
    Ul Rehman, Faisal
    Zhang, Xiaochun
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [3] Nivolumab plus Ipilimumab in Non-Small-Cell Lung Cancer
    Bersanelli, Melissa
    Tiseo, Marcello
    Banna, Giuseppe L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 874 - 875
  • [4] Nivolumab plus ipilimumab in non-small-cell lung cancer
    Reck, Martin
    Borghaei, Hossein
    O'Byrne, Kenneth J.
    [J]. FUTURE ONCOLOGY, 2019, 15 (19) : 2287 - 2302
  • [5] Nivolumab in non-small-cell lung cancer with EGFR mutation
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Yasuda, Y.
    Funazo, T.
    Hirai, T.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (03) : 777 - 778
  • [6] Nivolumab for squamous-cell non-small-cell lung cancer
    Yaqub, Farhat
    [J]. LANCET ONCOLOGY, 2015, 16 (07): : E319 - E319
  • [7] Perioperative Nivolumab and Chemotherapy in Non-Small-Cell Lung Cancer Reply
    Provencio, Mariano
    Massuti, Bartomeu
    Romero, Atocha
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (16): : 1534 - 1535
  • [8] Duration of nivolumab for pretreated, advanced non-small-cell lung cancer
    Geier, Margaux
    Descourt, Renaud
    Corre, Romain
    Leveiller, Guillaume
    Lamy, Regine
    Goarant, Eric
    Bizec, Jean-Louis
    Bernier, Cyril
    Quere, Gilles
    Amrane, Karim
    Gaye, Elisabeth
    Lucia, Francois
    Burte, Emilie
    Chouaid, Christos
    Robinet, Gilles
    [J]. CANCER MEDICINE, 2020, 9 (19): : 6923 - 6932
  • [9] Nivolumab plus Ipilimumab in Non-Small-Cell Lung Cancer Reply
    Hellmann, Matthew D.
    Ramalingam, Suresh S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 875 - 875
  • [10] Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
    Hellmann, M. D.
    Paz-Ares, L.
    Bernabe Caro, R.
    Zurawski, B.
    Kim, S. -W.
    Carcereny Costa, E.
    Park, K.
    Alexandru, A.
    Lupinacci, L.
    de la Mora Jimenez, E.
    Sakai, H.
    Albert, I.
    Vergnenegre, A.
    Peters, S.
    Syrigos, K.
    Barlesi, F.
    Reck, M.
    Borghaei, H.
    Brahmer, J. R.
    O'Byrne, K. J.
    Geese, W. J.
    Bhagavatheeswaran, P.
    Rabindran, S. K.
    Kasinathan, R. S.
    Nathan, F. E.
    Ramalingam, S. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 2020 - 2031
12345